{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-014716","form_type":"8-K","ticker":"MTVA","cik":"0001638287","company_name":"MetaVia Inc.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.646186+00:00","generated_at":"2026-06-11T11:25:54.863358+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"NeuroBo Pharmaceuticals appoints Hyung Heon Kim as Chief Executive Officer and President","bullets":["Hyung Heon Kim appointed CEO, President, and Principal Financial Officer effective August 11, 2023, succeeding interim CEO Joseph Hooker.","Kim previously served as General Counsel and Senior Vice President of Dong-A ST, which holds approximately 60% of NeuroBo's common stock.","Kim received an employment agreement with a $450,000 base salary, 50% target bonus, and a restricted stock unit award of 625,064 shares.","Joseph Hooker's departure as interim CEO was unrelated to any disagreement with the company on operations or policies.","Board committee changes include appointments of Mark A. Glickman, Na Yeon Kim, D. Gordon Strickland, and Andrew I. Koven to various committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-014716","json":"https://secwatch.observer/filing/0001558370-23-014716.json","markdown":"https://secwatch.observer/filing/0001558370-23-014716.md","text":"https://secwatch.observer/filing/0001558370-23-014716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638287/000155837023014716/0001558370-23-014716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638287/000155837023014716/nrbo-20230810x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T11:25:54.863358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fb2fef91e4","claim":"Hyung Heon Kim was appointed as Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer at MetaVia Inc..","evidence_excerpt":"appointed Mr. Hyung Heon Kim, a member of the Board, as the Company’s Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer effective as of August 11, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000155837023014716/0001558370-23-014716-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}